Analyses how to better integrate public policy with the pharmaceutical regime in Hong Kong. Will appeal to students, scholars and policymakers in law, public policy and pharmaceutical patents, as well as policymakers, international NGOs, think tanks and health organizations devoted to access of essential drugs.
Analyses how to better integrate public policy with the pharmaceutical regime in Hong Kong. Will appeal to students, scholars and policymakers in law, public policy and pharmaceutical patents, as well as policymakers, international NGOs, think tanks and health organizations devoted to access of essential drugs.
Bryan Mercurio is Professor of Law, Associate Dean (Research) and Vice Chancellor's Outstanding Fellow of the Faculty of Law at The Chinese University of Hong Kong. He is a leading expert in the intersection between trade law and intellectual property rights.
Inhaltsangabe
1. Introduction 2. The contextual framework of Hong Kong's pharmaceutical patent laws and policy 3. Standards of patentability 4. Extension of patent terms for pharmaceutical products 5. Exceptions to exclusive rights 6. Test data exclusivity 7. Patent linkage 8. Conclusion.
1. Introduction 2. The contextual framework of Hong Kong's pharmaceutical patent laws and policy 3. Standards of patentability 4. Extension of patent terms for pharmaceutical products 5. Exceptions to exclusive rights 6. Test data exclusivity 7. Patent linkage 8. Conclusion.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309